We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » More Clarity on Roles, Terminology Sought on IRB Draft Guidance
More Clarity on Roles, Terminology Sought on IRB Draft Guidance
February 1, 2013
Industry and patient advocacy groups are asking the FDA to clarify roles and terminologies in its recent draft guidance on oversight of investigators and sites and IND approvability.